30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The best-laid plans go oft awry: synaptogenic growth factor signaling in neuropsychiatric disease

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Growth factors play important roles in synapse formation. Mouse models of neuropsychiatric diseases suggest that defects in synaptogenic growth factors, their receptors, and signaling pathways can lead to disordered neural development and various behavioral phenotypes, including anxiety, memory problems, and social deficits. Genetic association studies in humans have found evidence for similar relationships between growth factor signaling pathways and neuropsychiatric phenotypes. Accumulating data suggest that dysfunction in neuronal circuitry, caused by defects in growth factor-mediated synapse formation, contributes to the susceptibility to multiple neuropsychiatric diseases, including epilepsy, autism, and disorders of thought and mood (e.g., schizophrenia and bipolar disorder, respectively). In this review, we will focus on how specific synaptogenic growth factors and their downstream signaling pathways might be involved in the development of neuropsychiatric diseases.

          Related collections

          Most cited references232

          • Record: found
          • Abstract: found
          • Article: not found

          The many faces of insulin-like peptide signalling in the brain.

          Central and peripheral insulin-like peptides (ILPs), which include insulin, insulin-like growth factor 1 (IGF1) and IGF2, exert many effects in the brain. Through their actions on brain growth and differentiation, ILPs contribute to building circuitries that subserve metabolic and behavioural adaptation to internal and external cues of energy availability. In the adult brain each ILP has distinct effects, but together their actions ultimately regulate energy homeostasis - they affect nutrient sensing and regulate neuronal plasticity to modulate adaptive behaviours involved in food seeking, including high-level cognitive operations such as spatial memory. In essence, the multifaceted activity of ILPs in the brain may be viewed as a system organization involved in the control of energy allocation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

            Schizophrenia is a highly debilitating mental disorder that affects approximately 1% of the general population, yet it continues to be poorly understood. Recent studies have identified variations in several genes that are associated with this disorder in diverse populations, including those that encode neuregulin 1 (NRG1) and its receptor ErbB4. The past few years have witnessed exciting progress in our knowledge of NRG1 and ErbB4 functions and the biological basis of the increased risk for schizophrenia that is potentially conferred by polymorphisms in the two genes. An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.

              AKT-GSK3beta signaling is a target of lithium and as such has been implicated in the pathogenesis of mood disorders. Here, we provide evidence that this signaling pathway also has a role in schizophrenia. Specifically, we present convergent evidence for a decrease in AKT1 protein levels and levels of phosphorylation of GSK3beta at Ser9 in the peripheral lymphocytes and brains of individuals with schizophrenia; a significant association between schizophrenia and an AKT1 haplotype associated with lower AKT1 protein levels; and a greater sensitivity to the sensorimotor gating-disruptive effect of amphetamine, conferred by AKT1 deficiency. Our findings support the proposal that alterations in AKT1-GSK3beta signaling contribute to schizophrenia pathogenesis and identify AKT1 as a potential schizophrenia susceptibility gene. Consistent with this proposal, we also show that haloperidol induces a stepwise increase in regulatory phosphorylation of AKT1 in the brains of treated mice that could compensate for an impaired function of this signaling pathway in schizophrenia.
                Bookmark

                Author and article information

                Journal
                Front Synaptic Neurosci
                Front Synaptic Neurosci
                Front. Synaptic Neurosci.
                Frontiers in Synaptic Neuroscience
                Frontiers Media S.A.
                1663-3563
                18 March 2014
                2014
                : 6
                : 4
                Affiliations
                [1] 1Department of Psychiatry, University of Michigan Ann Arbor, MI, USA
                [2] 2Molecular and Behavioral Neuroscience Institute, University of Michigan Ann Arbor, MI, USA
                [3] 3Department of Neurology, F.M. Kirby Neurobiology Center, Harvard Medical School, Boston Children's Hospital Boston, MA, USA
                Author notes

                Edited by: Akira Yoshii, University of Illinois at Chicago, USA

                Reviewed by: Ka Wan Li, VU University, Netherlands; Ki Ann Goosens, Massachusetts Institute of Technology, USA

                *Correspondence: Hisashi Umemori, Harvard Medical School, Boston Children's Hospital, 300 Longwood Avenue, Center for Life Sciences 13074, Boston, MA 02115, USA e-mail: hisashi.umemori@ 123456childrens.harvard.edu

                This article was submitted to the journal Frontiers in Synaptic Neuroscience.

                Article
                10.3389/fnsyn.2014.00004
                3957327
                24672476
                dd750529-4895-4a7e-8748-e2d5bc27f888
                Copyright © 2014 Williams and Umemori.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 16 December 2013
                : 21 February 2014
                Page count
                Figures: 4, Tables: 1, Equations: 0, References: 285, Pages: 20, Words: 15938
                Categories
                Neuroscience
                Review Article

                Neurosciences
                synapse,synaptogenesis,growth factor,psychiatry,mental illness
                Neurosciences
                synapse, synaptogenesis, growth factor, psychiatry, mental illness

                Comments

                Comment on this article